Schwerpunkt Logo
Merck & Co., Inc. (MRK : NYQ)
Sector: Healthcare | Industry: Drug Manufacturers - General
$152.55
+3.56 (+2.39%)
MARKET CAP
$376.37B
FCF YIELD
4.03%
CURRENT PRICE
$152.55
P/E RATIO
122.04x
Overview Financial Statements Metrics History DCF Valuation
FILTER LINE ITEMS:
INCOME STATEMENT (ANNUAL - 3-YEAR VIEW)
Financial Line Item 2025-12-31 2024-12-31 2023-12-31
1. REVENUE
Operating Revenue $65.01B $64.17B $60.12B
Total Revenue $65.01B $64.17B $60.12B
2. OPERATING EXPENSES
Reconciled Cost Of Revenue $16.38B $15.19B $16.13B
Interest Expense $1.36B $1.27B $1.15B
Tax Provision $2.80B $2.80B $1.51B
Operating Expense $26.52B $28.75B $41.03B
Research And Development $15.79B $17.94B $30.53B
Selling General And Administration $10.73B $10.82B $10.50B
Cost Of Revenue $16.38B $15.19B $16.13B
Total Expenses $42.90B $43.95B $57.16B
3. NET INCOME & EARNINGS DETAILS
Tax Effect Of Unusual Items $-112.34M $-73.39M $-132.09M
Tax Rate For Calcs 13.31% 14.06% 21.00%
Normalized EBITDA $29.11B $26.23B $7.54B
Total Unusual Items $-844.00M $-522.00M $-629.00M
Total Unusual Items Excluding Goodwill $-844.00M $-522.00M $-629.00M
Net Income From Continuing Operation Net Minority Interest $18.25B $17.12B $365.00M
Reconciled Depreciation $5.84B $4.50B $3.87B
EBITDA $28.26B $25.71B $6.91B
EBIT $22.42B $21.21B $3.04B
Net Interest Income $-1.01B $-856.00M $-781.00M
Interest Income $343.00M $415.00M $365.00M
Normalized Income $18.99B $17.57B $861.91M
Net Income From Continuing And Discontinued Operation $18.25B $17.12B $365.00M
Diluted Average Shares 2.51B 2.54B 2.61B
Basic Average Shares 2.47B 2.53B 2.61B
Diluted EPS $7.28 $6.74 $0.14
Basic EPS $7.38 $6.77 $0.14
Diluted NI Availto Com Stockholders $18.25B $17.12B $365.00M
Minority Interests $-9.00M $-16.00M $-12.00M
Net Income Including Noncontrolling Interests $18.26B $17.13B $377.00M
Net Income Discontinuous Operations - - $0.00
Net Income Continuous Operations $18.26B $17.13B $377.00M
Pretax Income $21.07B $19.94B $1.89B
Other Income Expense $-26.00M $571.00M $-284.00M
Other Non Operating Income Expenses $818.00M $1.09B $345.00M
Special Income Charges $-889.00M $-309.00M $-599.00M
Restructuring And Mergern Acquisition $889.00M $309.00M $599.00M
Gain On Sale Of Security $45.00M $-213.00M $-30.00M
Net Non Operating Interest Income Expense $-1.01B $-856.00M $-781.00M
Interest Expense Non Operating $1.36B $1.27B $1.15B
Interest Income Non Operating $343.00M $415.00M $365.00M
Operating Income $22.11B $20.22B $2.95B
Gross Profit $48.63B $48.98B $43.99B
Net Income Common Stockholders $18.25B $17.12B $365.00M
Net Income $18.25B $17.12B $365.00M
FINANCIAL RATIOS & STATS
Financial Metric Value
Trailing P/E 122.04x
Forward P/E 15.99x
Price-to-Book (P/B) 8.98x
Price-to-Sales (P/S) 5.65x
Net Profit Margin (Net Income / Revenue) 4.77%
Operating Profit Margin (EBIT / Revenue) -0.24%
Return on Equity (ROE) 6.96%
Return on Assets (ROA) 11.87%
Dividend Rate $3.40
Dividend Yield 2.23%
Ex-Dividend Date 2026-09-15
Next Earnings Date 2026-10-29